Publications by authors named "Isha John"

Claim this Profile
G
Glucagon-like peptide-1 receptor agonist versus sodium-glucose cotransporter-2 inhibitor persistence in Medicare Advantage beneficiaries with type 2 diabetes, cardiovascular risk, and obesity.
Andy Bowe, Mary Hayes, Isha John, Monica Diaz, Suzanne Dixon

Diabetes Obes Metab· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health care resource utilization and costs in Medicare Advantage beneficiaries using glucagon-like peptide-1 receptor agonists vs sodium-glucose cotransporter-2 inhibitors.
Insiya B Poonawalla, Petir Abdal, Mary Hayes, Isha John, Monica Diaz

J Manag Care Spec Pharm· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Home versus outpatient hospital intravenous immunoglobulin infusion and health care resource utilization.
Jeremiah Rastegar, Victoria T Brown, Isha John, Suzanne W Dixon, Elizabeth Rodman

J Am Pharm Assoc (2003)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Eliminating Intermediate Severity Drug-Drug Interaction Alerts on Overall Medication Alert Burden and Acceptance Rate.
Amy M Knight, Joyce Maygers, Kimberly A Foltz, Isha S John, Hsin Chieh Yeh

Appl Clin Inform· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis